US Stock MarketDetailed Quotes

KRYS Krystal Biotech

Watchlist
  • 197.420
  • +0.510+0.26%
Close Nov 29 13:00 ET
  • 197.420
  • 0.0000.00%
Post 17:01 ET
5.68BMarket Cap110.91P/E (TTM)

Krystal Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
879.91%83.84M
70.28M
45.25M
50.7M
42.14M
8.56M
0
0
0
0
Operating revenue
879.91%83.84M
--70.28M
--45.25M
--50.7M
--42.14M
--8.56M
--0
--0
--0
--0
Cost of revenue
2,897.31%6.68M
6.01M
2.42M
3.09M
2.87M
223K
0
0
0
0
Gross profit
825.92%77.16M
64.28M
42.83M
47.61M
39.27M
8.33M
0
0
0
0
Operating expense
23.01%42.22M
13.56%43.21M
1.91%37.02M
20.50%144.83M
3.92%36.13M
9.14%34.33M
32.33%38.05M
44.01%36.32M
76.05%120.2M
58.95%34.77M
Selling and administrative expenses
21.17%28.71M
6.65%27.63M
8.42%26.06M
26.59%98.4M
3.05%24.76M
18.87%23.7M
45.01%25.9M
51.09%24.04M
92.46%77.74M
86.76%24.03M
Research and development costs
27.11%13.51M
28.32%15.58M
-10.83%10.96M
9.35%46.43M
5.86%11.37M
-7.70%10.63M
11.52%12.14M
31.93%12.29M
52.28%42.46M
19.23%10.74M
Operating profit
234.39%34.93M
155.37%21.07M
116.01%5.82M
19.11%-97.23M
109.02%3.14M
17.35%-25.99M
-32.33%-38.05M
-44.01%-36.32M
-76.05%-120.2M
-58.95%-34.77M
Net non-operating interest income expense
8.84%7.34M
54.59%7.48M
116.00%7.62M
333.33%22.62M
176.54%7.52M
320.99%6.74M
650.08%4.84M
1,271.98%3.53M
503.17%5.22M
3,784.29%2.72M
Non-operating interest income
----
54.59%7.48M
116.00%7.62M
333.33%22.62M
----
----
--4.84M
1,271.98%3.53M
2,550.25%5.22M
3,784.29%2.72M
Non-operating interest expense
----
----
----
--0
----
----
----
----
--0
----
Total other finance cost
-8.84%-7.34M
----
----
----
----
---6.74M
----
----
----
----
Other net income (expense)
-112.50%-12.5M
-12.5M
0.00%-12.5M
450.00%87.5M
0
100M
50.00%-12.5M
-25M
0
Special income (charges)
-112.50%-12.5M
---12.5M
0.00%-12.5M
450.00%87.5M
--0
--100M
--0
50.00%-12.5M
---25M
--0
-Less:Other special charges
112.50%12.5M
--12.5M
0.00%12.5M
-450.00%-87.5M
--0
---100M
----
-50.00%12.5M
--25M
--0
Income before tax
-63.13%29.77M
148.31%16.05M
102.06%932K
109.21%12.9M
133.25%10.66M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
Income tax
2.59M
477K
1.97M
1.97M
0
0
0
Net income
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
Net income continuous Operations
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
Minority interest income
Net income attributable to the parent company
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-66.34%27.18M
146.88%15.57M
102.06%932K
107.81%10.93M
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.3M
-101.20%-139.98M
-46.99%-32.05M
Basic earnings per share
-67.01%0.95
143.20%0.54
101.70%0.03
107.29%0.4
125.60%0.32
346.15%2.88
-13.64%-1.25
11.56%-1.76
-75.40%-5.49
-31.58%-1.25
Diluted earnings per share
-67.38%0.91
142.40%0.53
101.70%0.03
107.10%0.39
124.80%0.31
338.46%2.79
-13.64%-1.25
11.56%-1.76
-75.40%-5.49
-31.58%-1.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 879.91%83.84M70.28M45.25M50.7M42.14M8.56M0000
Operating revenue 879.91%83.84M--70.28M--45.25M--50.7M--42.14M--8.56M--0--0--0--0
Cost of revenue 2,897.31%6.68M6.01M2.42M3.09M2.87M223K0000
Gross profit 825.92%77.16M64.28M42.83M47.61M39.27M8.33M0000
Operating expense 23.01%42.22M13.56%43.21M1.91%37.02M20.50%144.83M3.92%36.13M9.14%34.33M32.33%38.05M44.01%36.32M76.05%120.2M58.95%34.77M
Selling and administrative expenses 21.17%28.71M6.65%27.63M8.42%26.06M26.59%98.4M3.05%24.76M18.87%23.7M45.01%25.9M51.09%24.04M92.46%77.74M86.76%24.03M
Research and development costs 27.11%13.51M28.32%15.58M-10.83%10.96M9.35%46.43M5.86%11.37M-7.70%10.63M11.52%12.14M31.93%12.29M52.28%42.46M19.23%10.74M
Operating profit 234.39%34.93M155.37%21.07M116.01%5.82M19.11%-97.23M109.02%3.14M17.35%-25.99M-32.33%-38.05M-44.01%-36.32M-76.05%-120.2M-58.95%-34.77M
Net non-operating interest income expense 8.84%7.34M54.59%7.48M116.00%7.62M333.33%22.62M176.54%7.52M320.99%6.74M650.08%4.84M1,271.98%3.53M503.17%5.22M3,784.29%2.72M
Non-operating interest income ----54.59%7.48M116.00%7.62M333.33%22.62M----------4.84M1,271.98%3.53M2,550.25%5.22M3,784.29%2.72M
Non-operating interest expense --------------0------------------0----
Total other finance cost -8.84%-7.34M-------------------6.74M----------------
Other net income (expense) -112.50%-12.5M-12.5M0.00%-12.5M450.00%87.5M0100M50.00%-12.5M-25M0
Special income (charges) -112.50%-12.5M---12.5M0.00%-12.5M450.00%87.5M--0--100M--050.00%-12.5M---25M--0
-Less:Other special charges 112.50%12.5M--12.5M0.00%12.5M-450.00%-87.5M--0---100M-----50.00%12.5M--25M--0
Income before tax -63.13%29.77M148.31%16.05M102.06%932K109.21%12.9M133.25%10.66M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M
Income tax 2.59M477K1.97M1.97M000
Net income -66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M
Net income continuous Operations -66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M
Minority interest income
Net income attributable to the parent company -66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -66.34%27.18M146.88%15.57M102.06%932K107.81%10.93M127.12%8.69M370.51%80.75M-18.15%-33.21M9.34%-45.3M-101.20%-139.98M-46.99%-32.05M
Basic earnings per share -67.01%0.95143.20%0.54101.70%0.03107.29%0.4125.60%0.32346.15%2.88-13.64%-1.2511.56%-1.76-75.40%-5.49-31.58%-1.25
Diluted earnings per share -67.38%0.91142.40%0.53101.70%0.03107.10%0.39124.80%0.31338.46%2.79-13.64%-1.2511.56%-1.76-75.40%-5.49-31.58%-1.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data